Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. (SHE:300357)
China · Delayed Price · Currency is CNY 21.11
+0.24 (1.15%)
Oct 28, 2026, 3:04 PM CST
SHE:300357 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Operating Revenue | 1,115 | 1,058 | 921.46 | 840.75 | 894.88 | 804.12 |
Other Revenue | 3.92 | 3.92 | 3.94 | 7.44 | 1.14 | 3.58 |
| 1,119 | 1,062 | 925.39 | 848.19 | 896.02 | 807.69 | |
Revenue Growth | 6.73% | 14.81% | 9.10% | -5.34% | 10.94% | 26.95% |
Cost of Revenue | 53.19 | 50.58 | 44.81 | 40.19 | 42.51 | 34.44 |
Gross Profit | 1,066 | 1,012 | 880.58 | 808 | 853.5 | 773.25 |
Selling, General & Admin | 504.08 | 479.11 | 434.65 | 385.28 | 359.63 | 333.97 |
Research & Development | 102.76 | 117.1 | 119.88 | 112.2 | 106.02 | 87.93 |
Other Operating Expenses | 17.99 | 9.63 | 7.84 | 4.57 | 4.53 | 3.78 |
Operating Expenses | 628.24 | 606.46 | 563.23 | 501.05 | 471.43 | 427.23 |
Operating Income | 437.62 | 405.37 | 317.36 | 306.95 | 382.07 | 346.02 |
Interest Expense | -0.79 | -0.79 | -1.06 | -1.31 | -0.44 | -0.36 |
Interest & Investment Income | 44.73 | 26.45 | 35.81 | 32.87 | 28.35 | 29.03 |
Currency Exchange Gain (Loss) | -0 | -0 | 0 | 0 | -0 | -0 |
Other Non Operating Income (Expenses) | 3.1 | -0.32 | -0.34 | -0.26 | -0.15 | -0.17 |
EBT Excluding Unusual Items | 484.66 | 430.7 | 351.76 | 338.25 | 409.82 | 374.52 |
Gain (Loss) on Sale of Investments | 6.48 | 3.43 | 2.43 | -0.67 | -0.88 | -0.1 |
Gain (Loss) on Sale of Assets | -0 | 0.63 | 0.57 | - | -0.27 | - |
Asset Writedown | -5.11 | -5.11 | -1.42 | -0.58 | -43.23 | -0.1 |
Other Unusual Items | -0.95 | 3.06 | 11.72 | 8.95 | 33.3 | 18.67 |
Pretax Income | 485.08 | 432.71 | 365.06 | 345.96 | 398.75 | 393 |
Income Tax Expense | 68.51 | 64.62 | 60.72 | 50.43 | 63.02 | 66.71 |
Earnings From Continuing Operations | 416.57 | 368.09 | 304.34 | 295.52 | 335.73 | 326.29 |
Minority Interest in Earnings | 10.79 | 12.85 | 13.48 | 14.66 | 13.05 | 11.7 |
Net Income | 427.36 | 380.94 | 317.82 | 310.18 | 348.77 | 337.99 |
Net Income to Common | 427.36 | 380.94 | 317.82 | 310.18 | 348.77 | 337.99 |
Net Income Growth | 9.46% | 19.86% | 2.46% | -11.06% | 3.19% | 21.38% |
Shares Outstanding (Basic) | 524 | 524 | 524 | 524 | 524 | 524 |
Shares Outstanding (Diluted) | 524 | 524 | 524 | 524 | 524 | 524 |
Shares Change | 0.00% | -0.01% | -0.00% | - | -0.00% | 0.00% |
EPS (Basic) | 0.82 | 0.73 | 0.61 | 0.59 | 0.67 | 0.65 |
EPS (Diluted) | 0.82 | 0.73 | 0.61 | 0.59 | 0.67 | 0.65 |
EPS Growth | 9.46% | 19.87% | 2.46% | -11.06% | 3.19% | 21.38% |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Dec '21 Dec 31, 2021 |
Free Cash Flow | 406.75 | 270.9 | 133.12 | 154.61 | 159.62 | 236.33 |
Free Cash Flow Per Share | 0.78 | 0.52 | 0.25 | 0.29 | 0.30 | 0.45 |
Dividend Per Share | 0.150 | 0.250 | 0.220 | 0.185 | 0.200 | 0.201 |
Dividend Growth | -31.82% | 13.64% | 18.92% | -7.50% | -0.50% | 25.62% |
Gross Margin | 95.25% | 95.24% | 95.16% | 95.26% | 95.25% | 95.74% |
Operating Margin | 39.11% | 38.16% | 34.29% | 36.19% | 42.64% | 42.84% |
Profit Margin | 38.19% | 35.86% | 34.34% | 36.57% | 38.92% | 41.85% |
Free Cash Flow Margin | 36.35% | 25.50% | 14.39% | 18.23% | 17.82% | 29.26% |
EBITDA | 492.1 | 455.18 | 360.94 | 338.38 | 402.44 | 366.11 |
EBITDA Margin | 43.97% | 42.84% | 39.00% | 39.89% | 44.91% | 45.33% |
D&A For EBITDA | 54.48 | 49.81 | 43.59 | 31.43 | 20.37 | 20.08 |
EBIT | 437.62 | 405.37 | 317.36 | 306.95 | 382.07 | 346.02 |
EBIT Margin | 39.11% | 38.16% | 34.29% | 36.19% | 42.64% | 42.84% |
Effective Tax Rate | 14.12% | 14.93% | 16.63% | 14.58% | 15.80% | 16.97% |
Revenue as Reported | 1,119 | 1,062 | 925.39 | 848.19 | 896.02 | 807.69 |